Journal of Cytology
Home About us Ahead of print Instructions Submission Subscribe Advertise Contact e-Alerts Login 
Users Online:2634
  Print this page  Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Thyroid Cytology in India: Contemporary Review and Meta-analysis
Shipra Agarwal,Deepali Jain
Journal of Pathology and Translational Medicine.2017;51(6)533
[DOI]
2Prospective study of bethesda categories III and IV thyroid nodules: Outcomes and predictive value of BRAFV600E mutation
ShigaRappai Chirayath,PraveenV Pavithran,Nithya Abraham,Vasantha Nair,Nisha Bhavani,Harish Kumar,UshaV Menon,ArunS Menon
Indian Journal of Endocrinology and Metabolism.2019;23(3)278
[DOI]
3Outcomes of Bethesda categories III and IV thyroid nodules over 5 years and performance of the Afirma gene expression classifier: A single-institution study
Kelsi E. Deaver,Bryan R. Haugen,Nikita Pozdeyev,Carrie B. Marshall
Clinical Endocrinology.2018;89(2)226
[DOI]
4Prevalencia y malignidad asociada de las citologías de categoría Bethesda III de nódulos tiroideos según el grupo «atipia citológica» o «atipia arquitectónica»
Luis García Pascual,Maria Lluïsa Surralles,Xavier Morlius,Laia Garcia Cano,Clarisa González Mínguez
Endocrinología, Diabetes y Nutrición.2018;65(10)577
[DOI]
5Prevalence and associated malignancy of Bethesda category III cytologies of thyroid nodules assigned to the “cytological atypia” or “architectural atypia” groups
Luis García Pascual,Maria Lluïsa Surralles,Xavier Morlius,Laia Garcia Cano,Clarisa González Mínguez
Endocrinología, Diabetes y Nutrición (English ed.).2018;65(10)577
[DOI]
6Assessment of The Bethesda System for Reporting Thyroid Cytopathology
Jennifer L Sauter,Heidi Lehrke,Xiaotun Zhang,Osamah T Al Badri,Rene Rodriguez-Gutierrez,Danae A Delivanis,Naykky Singh Ospina,Diane Donegan,Oksana Hamidi,Nicole Iñiguez-Ariza,Anu Sharma,Nana Esi N Kittah,Shrikant U Tamhane,Maria D Hurtado Andrade,Anupam Kotwal,Sarah M Jenkins,Grant Spears,Michael Rivera,Diana S Dean,Michael R Henry
American Journal of Clinical Pathology.2019;152(4)502
[DOI]
7Subcategorisation of AUS/FLUS thyroid lesions as per the 2017 Bethesda System for Reporting Thyroid Cytopathology: a retrospective study from a tertiary care centre analysing risk of malignancy (ROM) of the different subcategories
Prerna Guleria,Shipra Agarwal,Venkateswaran K Iyer,Deepali Jain,Sandeep R Mathur,Diksha Yadav
Journal of Clinical Pathology.2019;72(11)771
[DOI]
8Subcategorisation of AUS/FLUS thyroid lesions as per the 2017 Bethesda System for Reporting Thyroid Cytopathology: a retrospective study from a tertiary care centre analysing risk of malignancy (ROM) of the different subcategories
Mehmet Ali Koç,Seher Demirer,Akin Firat Kocaay
Journal of Clinical Pathology.2019;72(11)99
[DOI]
  Search 
  The Journal 
  Site Statistics 
  Addresses 
  My Preferences 
  Online Submission 

Submit articles
Email alerts
Join us
Most popular articles
Recommend this journalRecommend this journal to your library